Joseph E. Cobb Jr., CPIP, has been appointed director of pharmaceutical development at Metrics, Inc. Mr. Cobb will manage all aspects of projects that involve early-phase solid oral dosage development. He also will oversee the company’s potent and cytotoxic drug development services, which include a dedicated and segregated potent facility.   Mr. Cobb has more than 20 years of industry experience, and holds the Certified Pharmaceutical Industry Professional credential from ISPE. He joined the co...